NCT06346561View on ClinicalTrials.gov

The Efficacy of Dexmedetomidine Versus Labetalol In Providing Controlled Hypotension In Dacryocystorhinostomy SurgeryA Comparative Randomized Prospective Study

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Nasolacrimal Duct Obstruction
Interventions
DRUG

Dexmedetomidine

the reduction of controlled hypotension and the control of hemodynamic responses of the body

DRUG

Labetalol

the reduction of controlled hypotension and the control of hemodynamic responses of the body

Trial Locations (1)

Unknown

RECRUITING

Sohag University hospitals, Sohag

All Listed Sponsors
lead

Sohag University

OTHER